Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
D000042:Absorption; D000284:Administration, Oral; D000327:Adsorption; D000328:Adult; D000931:Antidotes; D001241:Aspirin / Q000378:metabolism*; D002606:Charcoal / Q000008:administration & dosage* / Q000494:pharmacology; D005079:Excipients; D005260:Female; D006801:Humans; D008297:Male; D008899:Mineral Oil / Q000494:pharmacology; D012459:Salicylates / Q000652:urine; D013649:Taste; D013997:Time Factors
D000931:Antidotes; D005079:Excipients; D012459:Salicylates; D002606:Charcoal; D008899:Mineral Oil; D001241:Aspirin